Ask questions and gain insights about this stock now with Rize AI
IDXX logo

IDEXX Laboratories, Inc.

IDXX

Stock Analysis

$531.32

+0.00 (+0.00%)• Live

IDEXX Laboratories, Inc. Analysis Dashboard - Stock Analysis and Financial Metrics

Historical Prices

for IDEXX Laboratories, Inc.

Key Financial Metrics

for IDEXX Laboratories, Inc.

2024 FY
P/E Ratio
47.63
Revenue Growth
+6.46%
EPS Growth
+5.90%
Market Cap
$42.16B
Dividend Yield
0.00%
Debt/Equity
0.73
ROIC
+35.27%
FCF Yield
+1.99%
View additional metrics

Valuation

P/B Ratio29.44
EV/Sales10.95

Financial Health

Current Ratio1.16
Return on Assets+33.16%

Analyst Recommendations

for IDEXX Laboratories, Inc.

20 analysts
Consensus: Buy

About

for IDEXX Laboratories, Inc.

Company Details

for IDEXX Laboratories, Inc.

Sector

Healthcare

Industry

Medical - Diagnostics & Research

CEO

Jonathan J. Mazelsky

Employees

11,000

Market Cap

42.73B

Exchange

NASDAQ Global Select

IPO Date

June 21, 1991

CIK

0000874716

ISIN

US45168D1046

CUSIP

45168D104

Country

US

Balance Sheet

for IDEXX Laboratories, Inc.

Cash Flow Statement

for IDEXX Laboratories, Inc.

Income Statement

for IDEXX Laboratories, Inc.

Rize ist ein KI-gestütztes Investment-Research-Terminal, das eine umfassende Aktienanalyse und Einblicke über ein intuitives Dashboard bietet.

News

No news available at the moment.